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1Abbreviations 
 
CFIA Canadian Food Inspection Agency  
DG AGRI Directorate General for Agriculture and Rural Development 
DG SANCO Directorate General for Health and Consumer Protection 
DG RTD Directorate General for Research and Innovation 
DNA Deoxyribonucleic acid 
DSB Double Strand Break 
EC European Commission 
EFSA European Food Safety Authority 
EU European Union 
GM Genetically Modified 
GMO Genetically Modified Organism 
IHCP Institute for Health and Consumer Protection  
IPTS Institute for Prospective Technological Studies  
JRC Joint Research Centre  
NPBT New Plant Breeding Technique 
NTWG New Techniques Working Group 
ODM Oligonucleotide-Directed Mutagenesis 
ORF Open Reading Frame 
PNT Plant with Novel Trait 
RdDM RNA-dependent DNA Methylation 
RNA Ribonucleic Acid  
ZFN Zinc Finger Nuclease  
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31 Introduction 
Recombinant DNA (deoxyribonucleic acid) techniques have been used in plant breeding 
since the 1980s. In many countries the existing legislation was not regarded as sufficient to 
regulate transgenic crops (and other genetically modified products) and so new legislation on 
biotechnology and genetically modified organisms (GMOs) was introduced in the 1980s and 
1990s. It generally provides for an authorisation process for experimental and commercial 
release, import and marketing and use of these new crops including a comprehensive risk 
assessment. 
Since the 1980s, many new plant breeding techniques (NPBTs) have been developed. Many 
of these new approaches deploy biotechnology. Although the applied methodology and 
changes achieved in the genome of the crops differ from earlier transgenic approaches the 
question still arises (in countries where GMOs are regulated under specific legislation) as to 
whether crops derived by these techniques should be classified as GMOs. 
 
42 The report 
In 2010 the IPTS together with the Institute for Health and Consumer Protection (IHCP), 
another institute of the JRC, conducted a study on "New plant breeding techniques: State-of-
the-art and prospects for commercial development"1. As a follow-up to the 2010 study and as 
part of the 2011 IPTS work programme, it was decided to organise an international workshop 
to discuss the regulatory approaches for NPBTs in different countries worldwide. This report 
provides a summary and evaluation of the presentations and discussions from the workshop. 
Chapter 3 of this report presents the participants in the workshop and discusses the 
geographic coverage. A short overview of the regulatory framework for biotechnology derived 
crops in six countries, mainly focusing on the legislation and GMO definitions, is provided in 
chapter 4. Chapter 5 presents the approaches for NPBTs in the six countries, and chapter 6 
provides a summary of considerations and decisions for specific groups of NPBTs. 
 
1 Lusser, M., Parisi, C., Plan, D. & Rodríguez-Cerezo, E. New plant breeding techniques. State-of-the-
art and prospects for commercial development. JRC Technical Report EUR 24760 EN. European 
Commission. Joint Research Centre (2011). ftp://ftp.jrc.es/pub/EURdoc/JRC63971.pdf 
53 Participants in the workshop and geographical coverage 
The workshop brought together experts from seven countries. The names and affiliations of 
all participants are listed in Annex 1 of this report. The European Union (EU) was 
represented by staff of the European Commission (EC), from the JRC, the Directorate 
General for Health and Consumers (DG SANCO), the Directorate General for Agriculture and 
Rural Development (DG AGRI), the Directorate General for Research and Innovation (DG 
RTD) and the European Food Safety Authority (EFSA).  
Experts from six further countries were invited: Argentina, Australia, Canada, Japan, the USA 
and South Africa. Argentina was represented by two experts from the Ministry of Agriculture 
who are involved in the regulatory process of GMOs in their country. The Australian 
participants came from the Office of the Gene Technology Regulator and academia (La 
Trobe University, Victoria). Canada was represented by one staff member from the Plant 
Biosafety Office of the Canadian Food Inspection Agency (CFIA) and one from the Canadian 
representation to the EU. The Japanese experts work for the National Food Research 
Institute and Tsukuba University respectively and are both involved in the risk assessment of 
GMOs. The participant from the USA came from academia and explicitly stressed that he did 
not represent the US regulator. South Africa was represented by one member of staff from 
the Department of Environmental Affairs and Tourism. A further invited expert from the 
Department of Agriculture, Forestry and Fisheries was not able to participate in the end but 
contributed to the preparation of the presentation from South Africa. 
Presentations and discussions covered the regulatory approaches for crops derived through 
biotechnology for all represented countries with the exception of the USA. Experience with 
the regulation of crops derived by new plant breeding techniques is very limited in a few 
countries and discussions are only just starting in the other countries. The information 
provided in this report represents current views and therefore in many cases is provisional or 
indicative. 
 
64 Regulatory framework for biotechnology derived crops  
When recombinant DNA techniques were adopted by plant breeders and the first GM plants 
reached the stage of cultivation (in the 1980s and 1990s), countries decided on different 
legal approaches for the regulation of the cultivation and marketing of these crops. While a 
few countries like the USA and Canada used existing legislation to regulate crops derived by 
the recombinant DNA technique, many other countries introduced specific GMO legislation. 
Participants in the workshop provided comprehensive presentations on the regulatory 
approaches in the represented countries (with the exception of the USA). The presentations 
can be accessed through the following link: 
http://ipts.jrc.ec.europa.eu/presentations/NPBT.cfm. The paragraphs below provide brief 
introductions to the six systems of the countries presented in the workshop.  
4.1 Argentina 
Argentina introduced a regulatory system for GM crops in 1991. The national legislation 
relevant for agricultural biotechnology is compiled in the "Marco Regulatorio de la 
Biotecnología Agropecuaria en la República Argentina"2. New biotechnology regulations 
have recently been adopted in Argentina3,4. For the commercial authorisation to cultivate GM 
crops and/or place them on the market, three favourable reports on (i) biosafety of the agro-
ecosystem, (ii) food and feed safety and (iii) impact on trade and production, are required. 
Argentina uses two complementary criteria when defining GMOs, (i) the definition of products 
of "modern biotechnology" as used in the Cartagena Protocol and (ii) the definition of "event" 
in the Argentinean legislation (for the definitions see Annex 3). In the case of ambiguity, the 
definition of "event" is decisive. Labelling is not mandatory for foods derived from GM crops. 
 
2 http://www.grupobiotecnologia.com.ar/comercio65/html/458423MarcoRegulatorioArgentino.pdf 
3 Resolution N° 763/2011 (Ministry of Agriculture, Livestock and Fisheries, MAGyP). Commercial 
approval.
Resolution No. 701/2011 (Secretariat of Agriculture, Livestock and Fisheries, SAGyP). Field trials 
and full dossier review 
Resolution N° 510/2011 (SAGyP). Economic impact.
http://www.minagri.gob.ar/site/agricultura/biotecnologia/55-OGM_COMERCIALES/index.php
4 Resolution No. 661/2011 (SAGyP): Production of regulated seed. 
http://www.minagri.gob.ar/site/agricultura/biotecnologia/60-
SOLICITUDES/___producciones/index.php
74.2 Australia 
In Australia, the Gene Technology Act 2000 and the Gene Technology Regulations 2001 
were introduced to cover the issues specific to GMOs which had not been already addressed 
by existing laws. Depending on the use of the product, the biotechnology legislation is 
applied in conjunction with other legislation such as the Australia New Zealand Food 
Standards Code and the Agricultural and Veterinary Chemicals Code Act (e.g. for herbicide 
tolerant or insect resistant crops). As in most countries, risk assessments (environmental and 
health) and authorisation are required for the cultivation of GMOs and their use as food. 
The Gene Technology Act 2000 includes the definition of GMOs (for the definition see Annex 
3). The Gene Technology Regulations 2001 lists techniques which are not classified as gene 
technology (Schedule 1A) and organisms that are not GMOs (Schedule 1). Labelling of GM 
food is mandatory under the Australia New Zealand Food Standards Code when novel DNA 
or a novel protein from an approved GM variety is present in the final product. 
4.3 Canada 
The Canadian Regulatory Framework for Biotechnology (1993) established the principles 
that apply to products of biotechnology. It was decided to continue using the existing 
legislation and that products derived through biotechnology are to be treated as any other 
novel product. This means that regulation is triggered by the novel trait of the product (plants 
with novel traits = PNTs, novel feeds and novel foods) and not by the process via which the 
trait is introduced. 
PNTs are defined by a law (for the definition see Annex 3) and the assessment of these 
products is based on science and decided case by case. When PNTs are used as food or 
feed, the legislation for novel food and feed will also apply. Currently in Canada labelling is 
required if there is a health or safety issue with the food which might be mitigated through 
labelling, e.g. if the nutritional value or composition has been changed or if an allergen is 
present. This applies to all novel food, GM or not. As for GMO labelling, there is a national 
standard for the voluntary labelling of foods derived through biotechnology. 
84.4 European Union 
In the EU, GMOs have been regulated since 1990. The legislation was amended and the 
scope clarified in the year 20015. In 2003 the GMO legislation was expanded to food and 
feed derived from GMOs in order to achieve an integrated approach covering food, feed and 
seeds. To guarantee transparency for consumers, labelling rules were  
introduced6,7,8. Crops falling under the GMO definition require risk assessments 
(environmental and food/feed safety) and authorisation before being marketed, used or 
cultivated. 
The legislation includes the GMO definition and three lists defining (i) techniques which give 
rise to GMOs, (ii) techniques which are not considered to result in GMOs such as in vitro 
fertilization, natural processes like conjugation, transduction, transformation and polyploidy 
induction and (iii) techniques of genetic modification which are excluded from the GMO 
legislation (for the definition and lists see Annex 3).  
4.5 Japan 
In Japan the primary law regulating organisms derived through biotechnology is the Act on 
the Conservation and Sustainable Use of Biological Diversity through Regulations on the Use 
of Living Modified Organisms (Cartagena Domestic Law)9 which is based on the Cartagena 
Protocol on Biosafety which was signed by the Japanese government in 2003. Depending on 
the use of the GMO, additional legislation, e.g. on food10 or feed safety11, applies.  
 
5 Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the 
deliberate release into the environment of genetically modified organisms and repealing Council 
Directive 90/220/EEC - OJ L 106, 17.4.2001, p. 1–39. 
6 Regulation (EC) No 1830/2003 of the European Parliament and of the Council of 22 September 2003 
concerning the traceability and labelling of genetically modified organisms and the traceability of 
food and feed products produced from genetically modified organisms and amending Directive 
2001/18/EC -  OJ L 268, 18.10.2003, p. 24-28. 
7 Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 
on genetically modified food and feed -  OJ L 268, 18.10.2003, p. 1–23 
8 Although this legislation in many cases covers also GM animals and microorganisms, the discussion 
in the workshop and consequently also in this report was restricted to plant breeding. 
9 Act on the Conservation and Sustainable Use of Biological Diversity through Regulations on the Use 
of Living Modified Organisms (Act No 97 of 2003). 
10 Food Sanitation Law and Food Safety Basic Law. 
11 Feed Safety Law. 
9The GM definition in the Cartagena Domestic Law follows the definition of the Cartagena 
Protocol of “living modified organisms resulting from modern biotechnology” (see Annex 3). 
This means that the Law covers living organisms produced by  
i. modern biotechnology such as recombinant DNA technology including self-cloning 
and/or recombinant DNA technique using genetic material (host, vector and foreign 
genes) derived from organism between which natural gene exchange is possible 
("natural occurrence") and  
ii. techniques for fusing of cells of organisms belonging to different taxonomic families 
("fusion techniques beyond taxonomic family") 
Possible exemptions12 for organisms obtained by self-cloning and/or "natural occurrence" are 
assessed and decided case by case (for each produced organism).  
Risk assessments (environmental, health and food and feed safety) have to be carried out 
for each individual GM product in order to obtain authorization for experimental and 
commercial release and for placing on the market. This process involves many different 
ministries (depending on the use of the product) and consequently is very complex. GMO 
labelling is regulated by the Food Sanitation Law and the Japanese Agricultural Standard 
Law. 
4.6 South Africa 
The primary South African piece of legislation in the context of the workshop is the 
Genetically Modified Organisms Act 15 of 1997, as amended in 200613. Additional legal 
provisions are included in environmental14 and food safety15 legislation, which includes 
labelling provisions. Since 2010 there is also a Consumer Protection Act, the GMO labelling 
provisions of which are yet to come into force.  
The legislation includes the GMO definition and a list of techniques for which the GMO Act 
does not apply which are similar to the definition and lists in the EU legislation (for the 
definition and list see Annex 3). Contained use, experimental release, import, export and 
 
12 Exemption means in this context that the produced organism falls under the Cartagena Domestic Law however 
the requirements of the law are not applied to the specific organism. 
13 http://www.info.gov.za/acts/1997/act15.htm 
14 National Environmental Management Act 107 of 1998 and National Environmental Management: 
Biodiversity Act of 2004. 
15 Foodstuffs Cosmetics Act of 1972. 
10
placing on the market for commercial cultivation or use or processing as food or feed of 
GMOs require authorisation. 
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5 Approaches for new plant breeding techniques 
Experience with the regulation of crops obtained by NPBTs is very limited globally. While 
initial decisions have already been taken in a few countries, discussions have only just 
started in others. The obligation of participants to treat certain information as confidential 
further restricted the information which could be presented and released in the workshop. 
The information provided in this report represents current views and therefore in many cases 
is provisional or indicative. 
The following summary of the approaches in the six represented countries is based on the 
presentations on the regulatory approaches provided by the workshop participants 
(http://ipts.jrc.ec.europa.eu/presentations/NPBT.cfm) and discussions during the 
workshop. 
5.1 Argentina 
The Argentinean authorities have so far not received any applications for authorisation of 
crops obtained through the NPBTs discussed in the workshop. However, it is presumed that 
decisions concerning the regulatory classifications of new plant breeding techniques will be 
possible on the basis of the current legislation. As mentioned in chapter 4.1, in the case of 
ambiguity the definition of "event" will be decisive. 
A group of experts in Argentina started to study the issue and reached preliminary 
conclusions for most of the techniques. The details are presented in chapter 6 for the specific 
groups of techniques and in the presentation provided by the participant from Argentina. 
According to the workshop participants from Argentina the study will be continued and will in 
due course lead to refined regulatory criteria. After a consultation process with developers, 
academia and researchers, decisions will be taken concerning certain techniques' inclusion 
in or exclusion from the GM legislation.  
5.2 Australia 
The GMO definition in the Australian law (see chapter 4.2 and Annex 3) also needs further 
discussion and interpretation when dealing with NPBTs. The Gene Technology Regulations 
2001 include a list of organisms that are not regarded as GMOs. Item 1 of this list16 is 
specifically relevant in the context of NPBTs. 
 
16 (1) A mutant organism in which the mutational event did not involve the introduction of any foreign 
nucleic acid (that is, non homologous DNA, usually from another species). 
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The Office of the Gene Technology Regulator has given advice on a few occasions on the 
interpretation of legislative provisions relevant to NPBTs. This advice has been given in 
response to specific questions, usually from researchers, and has not been made public. It is 
likely that use of the ZFN-1 technique, applied to achieve a deletion in the genome, would 
not result in the crops being regarded as GMOs. Also cisgenesis, according to the strict 
definition used here, when one piece of DNA from the same species without any further 
modification is introduced, will most likely not be regarded as GMO. However, these matters 
are still under consideration and will continue to be addressed on a case-by-case basis. The 
Office is currently considering a specific question regarding ZFN-1 and ZFN-2 techniques. 
The Office has not publicly given general guidance for specific new techniques, but rather 
encourages developers to contact them with specific cases where the regulatory status is not 
clear. It intends to continue with this approach until it has more experience with NPBTs.  
5.3 Canada 
As already discussed in chapter 4.3, crops obtained through biotechnology are treated in the 
same way as any other crops under the Canadian legislation. Crops with novel traits have to 
pass safety assessments and an authorisation process, independent of the technology used. 
Novel traits can be introduced by traditional breeding, cell fusion, mutagenesis, recombinant 
DNA techniques and other techniques. Therefore, the Canadian regulatory process does not 
need to be changed or specifically adapted for crops derived through NPBTs. The Canadian 
participant in the workshop discussed as an example herbicide tolerant (HT) crops that 
present issues such as the transfer of the HT trait to related plants, management of 
volunteers or emergence of herbicide resistant weeds. According to the Canadian regulatory 
framework, crops with such traits have to be managed similarly, and therefore trigger 
regulation regardless of the technique they were developed by. If a crop with the same trait 
has already been authorised before, it may not be necessary to submit any new data for a 
follow-up product that fits specified criteria. 
The Canadian participant in the workshop presented the case of a sulfonylurea tolerant 
canola developed through one of the NPBTs, which triggered legislation because of 
herbicide tolerance trait present (the development method was not considered during the 
regulatory status determination). 
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5.4 European Union 
In the EU, the discussions on new plant breeding techniques started in 2007. Within the 
European Commission, DG SANCO, the JRC and EFSA are dealing with the three following 
aspects of NPBTs in accordance with their competencies. 
Regulatory aspects
A working group of experts from EU Member States was established by the EC in 2007 (New 
Techniques Working Group, NTWG). On the basis of the EU GMO definition (see chapter 4.4 
and Annex 3) they are evaluating whether certain new techniques constitute genetic 
modification and, if so, whether the resulting organisms fall within the scope of the EU GMO 
legislation. The report of the working group, once finalised, will be presented to the Member 
States for further discussion and decisions, which will presumably be carried out technique 
by technique.  
Technical and socio-economic aspects 
In 2010 the IPTS and the IHCP of the EC's JRC conducted a study on "New plant breeding 
techniques: State-of-the-art and prospects for commercial development"17. It investigated the 
degree of development and adoption of NPBTs by the commercial breeding sector, 
discussed drivers and constraints for further development of new plant varieties on these 
techniques and evaluated the technical possibilities for detecting and identifying crops 
produced by NPBTs. 
Safety aspects
EFSA received a mandate in 2011 to address the safety aspects of new plant breeding 
techniques. They have been asked to provide an opinion on whether current guidance is 
appropriate for the risk assessment of organisms derived through new techniques and also 
on the possible risks of these organisms. The evaluation is carried out technique by 
technique, starting with cisgenesis. 
 
17 Lusser, M., Parisi, C., Plan, D., Rodríguez-Cerezo, E., 2011. New plant breeding techniques. State-
of-the-art and prospects for commercial development. European Commission, JRC Technical 
Report EUR 24760 EN 
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5.5 Japan 
In Japan, officials from the six ministries responsible for regulating GMOs meet for the 
purposes of consulting and coordinating their activities under the Cartagena Domestic Law 
(see chapter 4.5). They collect information related to NPBT crops and discuss and consider 
their classification as GMOs or non-GMOs on a case-by-case basis, but they have not 
reached conclusions so far. 
The GMO definition (see Annex 3) under Japanese law follows the definition of “living 
modified organisms resulting from modern biotechnology” in the Cartagena Protocol. As 
discussed in chapter 4.5, organisms obtained by self-cloning or recombinant DNA technique 
using genetic material (host, vector and foreign genes) derived from organism between 
which natural gene exchange is possible ("natural occurrence") may be exempted from the 
requirements of the Cartagena Domestic Law. Cisgenesis could be interpreted as falling 
under these definitions. However, the exemption rule for "self-cloning" and "natural 
occurrence" is only applied to microorganisms and not to plants or animals. Therefore, for 
crops derived through cisgenesis an application for the approval of research and 
development has to be submitted. The Japanese participant discussed grafting on GM 
rootstocks as a second example. He explained that the chimeric plant (for environmental 
safety) and the fruits (because of the possible migration of foreign products such as mRNA 
or proteins) should be treated as GM, whereas the progeny or seeds should be seen as non-
GM. 
5.6 South Africa 
The South African participant in the workshop stated that the experience of her country with 
NPBTs is limited to some research activities. No regulatory decisions have been taken yet 
and no applications concerning NPBTs have been received. Initial considerations have 
started following the invitation to the JRC workshop. As the GMO definition in South African 
law is similar to the EU definition (see chapter 4.6 and Annex 3), similar difficulties are 
expected. It is intended to address the techniques case by case, starting with agro-infiltration, 
grafting on GM rootstock and cisgenesis/intragenesis. 
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6 Approaches and decisions for specific groups of new plant breeding techniques 
The second part of the workshop was dedicated to a discussion on decisions and 
considerations concerning the regulatory status of groups of NPBTs in the countries 
represented in the workshop. A presentation on the rationale for the grouping of the NPBTs 
discussed was given during the workshop and is accessible through the following link 
http://ipts.jrc.ec.europa.eu/presentations/NPBT.cfm. Short definitions of the discussed 
techniques are listed in Annex 4. 
The roundtable discussions on each group of techniques were introduced with presentations 
on information from the 2010 study on NPBTs18. They summarised information on the 
intended and unintended changes in the genome of crops obtained by NPBTs and the 
possibility of detecting and identifying these crops. The results from the evaluation of the 
commercial pipeline for the crops show the urgency for regulatory decisions. 
The following discussions apply only for those countries where a specific legislation for 
biotechnology derived crops exists. The specific situation in Canada is discussed in chapters 
4.3 and 5.3. 
6.1 Targeted mutagenesis 
The following techniques were discussed: 
• Zinc Finger Nuclease technologies (ZFN-1, ZFN-2 and ZFN-3) 
• Oligonucleotide directed mutagenesis (ODM) 
• Meganuclease technique 
Experts from most participating countries regard it as very likely that the ZFN-1 technique 
and meganuclease techniques whereby no template sequences are introduced will be 
classified as non-GM. The EU has not yet concluded its assessment. Products of the ZFN-3 
technique, or meganuclease techniques whereby a long DNA sequence is introduced, are 
products of recombinant DNA techniques (GMOs) and consequently fall under chapter 6.5. 
Between ZFN-3 and ZFN-2 or ODM, it generally appears to be unclear which kind, and 
specifically what size, of change obtained by the technique should decide between GMO and 
non-GMO. The representatives of Argentina specified that in their country ZFN-2 and 
 
18 Lusser, M., Parisi, C., Plan, D. & Rodríguez-Cerezo, E. New plant breeding techniques. State-of-
the-art and prospects for commercial development. JRC Technical Report EUR 24760 EN. 
European Commission. Joint Research Centre (2011). ftp://ftp.jrc.es/pub/EURdoc/JRC63971.pdf 
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meganuclease techniques where coding sequences are introduced or open reading frames 
(ORFs) modified will most likely be treated on a case-by-case basis. The representative of 
the Australian Office of the Gene Technology Regulator informed that the Office has given 
advice to indicate that products of the ZFN-2 technique and ODM are likely to be considered 
GMOs if any nucleotide is changed. Other experts, however, stressed that products obtained 
by ZFN-1 and ZFN-2 techniques cannot be distinguished from crops derived through 
mutagenesis induced by chemicals or irradiation (and this also applies to products obtained 
by ODM) and, therefore, should be regulated in the same way.  
6.2 Cisgenesis and intragenesis 
All participants agreed that in their countries intragenesis will most likely be treated in the 
same way as transgenesis. Cisgenesis is also expected to be classified as a technique of 
genetic modification with the exception of specific approaches of cisgenesis in a few 
countries. The Australian participant in the workshop stated that cisgenesis with a very 
narrow definition (introduced gene from the same species and without any rearrangements, 
no foreign DNA, and no T-DNA border sequences) would probably not fall under the 
Australian GMO definition. However, the Office of the Gene Technology Regulator has not 
yet dealt with such a case. The experts noted that applications of cisgenesis falling under this 
narrow definition (obtained through a biolistic approach) are rare. Also the expert from South 
Africa indicated that, according to preliminary discussions in her country, some approaches 
of cisgenesis might be treated as non-GM. The Japanese expert confirmed that crops 
obtained by cisgenesis are currently treated as GMOs in his country. Also the Argentinean 
experts group concluded that cisgenesis should not be treated any differently from 
transgenesis.  
6.3 Transgenic construct driven breeding (negative segregants) 
A transgene encoding an RNAi construct or a dominant-negative protein is present in (e.g. 
inserted into the genome of) an inducer line. The expression of the transgene leads to the 
inhibition of gene expression or the inhibition of a protein function, respectively. This leads to 
an effect such as suppression of the meiotic recombination or early flowering. The inducer 
transgene is segregated out during further breeding and is therefore not present in the final 
product (negative segregant). 
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The following techniques were discussed: 
• RNA-dependent DNA methylation (RdDM) 
• Reverse breeding 
The regulatory situation of negative segregants appears to be unclear in most countries. The 
experts from Argentina informed that, according to a preliminary discussion in their expert 
group, negative segregants should be excluded from the GMO legislation. The participant 
from Australia stated that a negative segregant would most likely not fall under the GMO 
definition of his country if no introduced trait is inherited. However, if an introduced trait is 
inherited (e.g. gene silencing generated by RdDM) then the progeny may fall under the 
Australian definition of a GMO even when the introduced DNA is not inherited. However, a 
submitted application concerning this issue has not yet been dealt with. The EU and South 
Africa have still to conclude on the classification of negative segregants. The participant from 
Japan stressed the importance of proving the absence of inserted DNA sequences.  
The special case of RdDM, where the methylation of certain regions of the DNA remains 
after segregating out the inserted gene, was also discussed. Here a more general problem is 
prevalent. The effect of gene silencing fades out in the following generations. The Canadian 
and Argentinean representatives mentioned that because of this instability of expression it is 
unclear how crops with such traits would be treated under the current regulatory framework. 
This question would need to be addressed.  
6.4 Others 
The other following techniques were discussed: 
• Grafting on GM rootstock 
• Agro-infiltration "sensu stricto" 
• Agro-infection 
As for grafting on GM rootstock, the experts stated that the rootstock is clearly GM and that 
an approval is required for the plant's release into the environment. Scientific questions still 
need to be answered, especially concerning the possible migration of molecules from the 
rootstock to the scion. In Japan fruits from such a graft are treated as GMOs (taking into 
account the possible trafficking of proteins and metabolites). However the progeny (seeds) 
are regarded as non-GM. The Argentinean group of experts concluded (preliminary opinion) 
that the fruits of these grafts should be assessed on a case-by-case basis. In Australia, fruits 
from grafts on GM rootstock will most likely not be regarded as GMOs, but may be classified 
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under the food legislation (Australia New Zealand Food Standards Code) as "food produced 
using gene technology" and may therefore require a pre-market safety assessment. In South 
Africa it was concluded that the use of the fruits should be taken into account for the 
assessment.  
Scientific questions still have to be addressed for agro-infiltration too, for example relating to 
the absence of Agrobacterium or if integration of the gene takes place. In Australia and 
Argentina progeny of infiltrated plants will most likely not be regarded as GMO if no 
Agrobacterium is present and no gene is integrated. In South Africa, agroinfiltration is used in 
research and therefore the regulatory status is under discussion. However no final view has 
been reached. The Japanese participant stressed the interest of researchers and breeders in 
the technique in his country.  
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Annex 2: Agenda and presentations 
 
AGENDA 
WORKSHOP "COMPARATIVE SITUATION OF NEW PLANT  
BREEDING TECHNIQUES"  
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European Commission       c/ Inca Garcilsaso 3 
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Institute for Prospective Technological Studies    Seville, Spain 
Chair:           Maria Lusser, JRC-IPTS 
Co-Chair:     Emilio Rodríguez Cerezo, JRC-IPTS 
 
Monday 12 September 2011  
Time Programme items Speaker 
14:00-14:10 Welcome Jacques Delincé 
AGRILIFE, Head of Unit 
 
Emilio Rodriguez Cerezo 
AGRILIFE, AGRITECH  
Action leader 
14:10-14:30 2010 JRC project "New Plant Breeding Techniques" Maria Lusser JRC-IPTS 
14:30-14:40 Challenges for detection of crops obtained by new plant 
breeding techniques 
Damien Plan, JRC-IHCP 
14:40-14:50 Discussion 
Session 1: Regulatory Framework for biotechnology derived crops with 
specific focus on new plant breeding in different countries/organisations 
14:50-15:10 Regulatory Framework for biotechnology derived crops with 
specific focus on new plant breeding techniques in the 
European Union 
Joachim Bollmann 
DG SANCO 
15:10-15:20 Discussion 
15:20-15:40 Regulatory Framework for biotechnology derived crops with 
specific focus on new plant breeding techniques in Canada 
Nataliya Dormann,  
Plant Biosafety Office 
15:40-15:50 Discussion 
15:50-16:10 Regulatory Framework for biotechnology derived crops with 
specific focus on new plant breeding techniques in Australia 
Will Tucker, Office of the 
Gene Technology 
Regulator of Australia 
16:10-16:20 Discussion 
16:20-16:50 Coffee break 
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Monday 12 September 2011 (continued) 
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Department of 
Environmental Affairs and 
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techniques: stage of development, practical experience, discussions on 
possible regulatory approaches, etc. 
9:50-11:00 New Plant Breeding Techniques – (1) Targeted Mutagenesis 
(ZFN 1 and 2 technologies, oligonucleotide directed 
mutagenesis, meganuclease technique) 
Short presentations & Round table discussion 
Fernando Zelaschi, 
Directorate of 
Biotechnology, Livestock 
and Fisheries 
Maria Lusser JRC-IPTS 
11:00-11:30 Coffee break 
11:30-12:30 New Plant Breeding Techniques – (2) Cisgenesis, Intragenesis 
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Maria Lusser JRC-IPTS 
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dependent DNA methylation) 
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Maria Lusser JRC-IPTS 
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Annex 3: Definitions of GMOs and related terms in the legislation of different countries 
 
ARGENTINA 
Cartagena Protocol on Biosafety 
Article 3. Use of Terms 
"Modern biotechnology" means the application of:  
a. In vitro nucleic acid techniques, including recombinant deoxyribonucleic acid (DNA) and 
direct injection of nucleic acid into cells or organelles, or  
b. Fusion of cells beyond the taxonomic family, that overcome natural physiological 
reproductive or recombination barriers and that are not techniques used in traditional 
breeding and selection; 
Resolution 701/2011 
Art.2, bullet 19. 
"Event" means "The joint and stable insertion into the plant genome of ONE (1) or more 
genes or DNA sequences that are part of a defined genetic construct".  
(Unofficial translation from Spanish)19 
19 Original legal text: "Evento de transformación individual, también referido como "evento": la 
inserción en el genoma vegetal en forma estable y conjunta, de UNO (1) o más genes o secuencias 
de ADN que forman parte de una construcción genética definida." 
http://www.minagri.gob.ar/site/agricultura/biotechnologia/55-OGM_COMERCIALES/index.php
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AUSTRALIA 
 
The Gene Technology Act 2000 
Section 10. Definitions 
genetically modified organism means any of the following 
(a) an organism that has been modified by gene technology; or 
(b) an organism that has inherited particular traits from an organism (the initial 
organism), being traits that occurred in the initial organism because of gene 
technology; or 
(c) anything declared by the regulations to be a genetically modified organism, or that 
belongs to a class of things declared by the regulations to be genetically modified 
organisms; 
but does not include: 
(d) a human being, if the human being is covered by paragraph (a) only because the 
human being has undergone somatic cell gene therapy; or 
(e) an organism declared by the regulations not to be a genetically modified 
organism, or that belongs to a class of organisms declared by the regulations not 
to be genetically modified organisms. 
Gene Technology Regulations 2001 
Schedule 1A 
Techniques that are not gene technology 
Item  Description of technique  
1 Somatic cell nuclear transfer, if the transfer does not involve genetically modified 
material.  
2 Electromagnetic radiation-induced mutagenesis.  
3 Particle radiation-induced mutagenesis.  
4 Chemical-induced mutagenesis.  
5 Fusion of animal cells, or human cells, if the fused cells are unable to form a viable 
whole animal or human.  
6 Protoplast fusion, including fusion of plant protoplasts.  
7 Embryo rescue.  
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8 In vitro fertilisation.  
9 Zygote implantation.  
10  A natural process, if the process does not involve genetically modified material.  
Examples 
Examples of natural processes include conjugation, transduction, transformation and 
transposon mutagenesis.  
 
Gene Technology Regulations 2001 
Schedule 1 
Organisms that are not genetically modified organisms 
Item  Description of organism  
1 A mutant organism in which the mutational event did not involve the introduction of 
any foreign nucleic acid (that is, non-homologous DNA, usually from another species).  
2 A whole animal, or a human being, modified by the introduction of naked 
recombinant nucleic acid (such as a DNA vaccine) into its somatic cells, if the introduced 
nucleic acid is incapable of giving rise to infectious agents.  
3 Naked plasmid DNA that is incapable of giving rise to infectious agents when 
introduced into a host cell.  
6 An organism that results from an exchange of DNA if:  
 (a)  the donor species is also the host species; and  
 (b)  the vector DNA does not contain any heterologous DNA.  
7 An organism that results from an exchange of DNA between the donor species and 
the host species if:  
(a)  such exchange can occur by naturally occurring processes; and  
(b)  the donor species and the host species are micro-organisms that:  
 (i)   satisfy the criteria in AS/NZS 2243.3:2010 for classification as Risk Group 1; and  
 (ii)  are known to exchange nucleic acid by a natural physiological process; and  
(c)  the vector used in the exchange does not contain heterologous DNA from any organism 
other than an organism that is involved in the exchange.  
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CANADA 
 
Seeds Regulations Part V 
 
“novel trait”, in respect of seed, means a characteristic of the seed that 
(a) has been intentionally selected, created or introduced into a distinct, stable population of 
cultivated seed of the same species through a specific genetic change, and 
(b) based on valid scientific rationale, is not substantially equivalent, in terms of its specific 
use and safety both for the environment and for human health, to any characteristic of a 
distinct, stable population of cultivated seed of the same species in Canada, having regard to 
weediness potential, gene flow, plant pest potential, impact on non-target organisms and 
impact on biodiversity; (caractère nouveau) 
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EUROPEAN UNION 
 
Directive 2001/18/EC on the deliberate release into the environment of 
genetically modified organisms 20 
Article 2 
Definitions 
For the purposes of this Directive: 
(1) "organism" means any biological entity capable of replication or of transferring genetic 
material; 
(2) "genetically modified organism (GMO)" means an organism, with the exception of 
human beings, in which the genetic material has been altered in a way that does not occur 
naturally by mating and/or natural recombination; 
Within the terms of this definition: 
(a) genetic modification occurs at least through the use of the techniques listed in Annex I 
A, part 1; 
(b) the techniques listed in Annex I A, part 2, are not considered to result in genetic 
modification; 
 
Article 3 
Exemptions 
1. This Directive shall not apply to organisms obtained through the techniques of genetic 
modification listed in Annex I B. 
20 Directive 2001/18/EC20 of the European Parliament and of the Council of 12 March 2001 on the 
deliberate release into the environment of genetically modified organisms and repealing Council 
Directive 90/220/EEC - Commission Declaration -  OJ L 106, 17.4.2001, p. 1–39 
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Directive 2001/18/EC on the deliberate release into the environment of 
genetically modified organisms 
ANNEX I A 
TECHNIQUES REFERRED TO IN ARTICLE 2(2) 
PART 1 
Techniques of genetic modification referred to in Article 2(2)(a) are inter alia: 
(1) recombinant nucleic acid techniques involving the formation of new combinations of 
genetic material by the insertion of nucleic acid molecules produced by whatever means 
outside an organism, into any virus, bacterial plasmid or other vector system and their 
incorporation into a host organism in which they do not naturally occur but in which they 
are capable of continued propagation; 
(2) techniques involving the direct introduction into an organism of heritable material 
prepared outside the organism including micro-injection, macro-injection and micro-
encapsulation; 
(3) cell fusion (including protoplast fusion) or hybridisation techniques where live cells with 
new combinations of heritable genetic material are formed through the fusion of two or 
more cells by means of methods that do not occur naturally. 
 
PART 2 
Techniques referred to in Article 2(2)(b) which are not considered to result in genetic 
modification, on condition that they do not involve the use of recombinant nucleic acid 
molecules or genetically modified organisms made by techniques/methods other than 
those excluded by Annex I B: 
(1) in vitro fertilisation, 
(2) natural processes such as: conjugation, transduction, transformation, 
(3) polyploidy induction. 
 
ANNEX I B 
TECHNIQUES REFERRED TO IN ARTICLE 3 
Techniques/methods of genetic modification yielding organisms to be excluded from the 
Directive, on the condition that they do not involve the use of recombinant nucleic acid 
molecules or genetically modified organisms other than those produced by one or more of 
the techniques/methods listed below are: 
(1) mutagenesis, 
(2) cell fusion (including protoplast fusion) of plant cells of organisms which can exchange 
genetic material through traditional breeding methods. 
28
JAPAN 
 
Act on the Conservation and Sustainable Use of Biological Diversity 
through Regulations on the Use of Living Modified Organisms (Act No 
97 of 2003) 
Article 2 (Definitions) 
(1) In this Act, "living modified organism" shall mean an organism that possesses nucleic 
acid, or replicated product thereof, obtained through use of any of the following 
technologies. 
(i) Those technologies as stipulated in the ordenance of the competent ministries, for 
the processing of nucleic acid extracellularly 
(ii) Those technologies as stipulated in the ordenance of the competent ministries, for 
the fusing of the cells of organisms belonging to different taxonomic families. 
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SOUTH AFRICA 
 
Genetically Modified Organisms Act [No. 15 of 1997] 
Definitions
1. In this Act, unless the context otherwise indicates-  
……. 
i. "genetically modified organism" means an organism the genes or genetic 
material of which has been modified in a way that does not occur naturally 
through mating or natural recombination or both, and "genetic modification" 
shall have a corresponding meaning; (xiii)  
…… 
 
Application of Act 
2. (1) This Act shall apply to-  
a. the genetic modification of organisms;  
b. the development, production, release, use and application of genetically 
modified organisms (including viruses and bacteriophages); and  
c. the use of gene therapy.  
2. This Act shall not apply to techniques-  
a. involving human gene therapy;  
b. in which recombinant DNA molecules or genetically modified organisms are 
not employed-  
i. in in vitro fertilisation in humans and animals;  
ii. in conjugation, transduction, transformation or any other natural 
process: and  
iii. in polyploidy induction;  
c. in which genetically modified organisms as recipient or parental organisms are 
not employed-  
i. in mutagenesis;  
ii. in the construction and use of somatic hybridoma cells; and  
iii. in cell fusion (including protoplast fusion) of plant cells.  
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Annex 4: Definitions of new plant breeding techniques 
 
Agro-infiltration:
Agro-infiltration ‘sensu stricto’: Non-germline tissues, mostly leaves, are infiltrated with a 
liquid suspension of Agrobacterium containing a genetic construct. The genetic construct is 
locally expressed at high level, without being integrated into the plant genome.  
Agro-infection: Non-germline tissues, typically leaves, are infiltrated with a construct 
containing the foreign gene in a full-length virus vector to facilitate spreading and expression 
of the target gene in the entire plant.  
Floral dip: Germline tissues, typically flowers, are immersed into a suspension of 
Agrobacterium containing a DNA construct in order to obtain transformation of some 
embryos that can be selected at the germination state. The aim is to obtain stably 
transformed plants. 
 
Cisgenesis and intragenesis:
A DNA sequence from the species itself or from a cross compatible species is inserted into 
the plant genome. In the case of cisgenesis, the inserted gene is unchanged with its own 
introns and regulatory sequences. In the case of intragenesis, the inserted DNA can be a 
new combination of DNA fragments from the species itself or from a cross compatible 
species. 
 
Grafting (on GM rootstock):  
A chimeric plant is produced by grafting a non-genetically modified scion on a genetically 
modified rootstock. 
 
Meganuclease technique: 
Meganucleases are proteins that specifically recognize target DNA sequences of 12 to over 
30 base pairs and create a double strand break (DSB) that activates repair mechanisms and 
DNA recombination. Similarly to ZFNs, the technique can be used for site specific 
mutagenesis or for targeted gene insertion by homologous recombination. Newly designed 
meganucleases can be produced in order to induce site-specific DNA recombination at a 
chosen locus in plant cell. 
 
Oligonucleotide directed mutagenesis (ODM):  
Oligonucleotides target homologous DNA and induce site-specific nucleotide substitutions, 
insertions or deletions through repair mechanisms. Oligonucleotides such as chimeric 
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oligonucleotides , consisting of DNA and RNA bases, and single stranded DNA 
oligonucleotides can be deployed for ODM in plants. 
 
Reverse Breeding:  
Homozygous parental lines are produced from selected heterozygous plants by suppressing 
meiotic recombination. This suppression is obtained through RNA interference-mediated 
downregulation of genes involved in the meiotic recombination process. Subsequently, 
double haploid (DH) homozygous lines are produced and hybridised in order to reconstitute 
the original genetic composition of the selected heterozygous plants. 
RNA-dependent DNA methylation (RdDM):  
Genes encoding RNAs which are homologous to plant sequences, like promoter regions, are 
delivered to the plant cells. These genes, once transcribed, give rise to the formation of small 
double stranded RNAs. They induce methylation of the homologous sequences and 
consequently inhibit their transcription. 
 
Zinc finger nuclease technology: 
ZFN-1: Genes encoding Zinc Finger Nucleases (ZFN) are delivered to plant cells without a 
repair template. The ZFN binds to a specific DNA sequence and generates a site-specific 
double strand break (DSB). The natural DNA-repair process through non-homologous end-
joining (NHEJ) leads to site-specific mutations, which consist of changes of single or few 
base pairs, short deletions or insertions. 
ZFN-2: Genes encoding Zinc Finger Nucleases (ZFN) are delivered to plant cells along with 
a short repair template. The ZFN binds to a specific DNA sequence and generates a site-
specific double strand break (DSB). Gene repair mechanisms generate site-specific point 
mutations like changes of single or few base pairs through homologous recombination and 
the copying of the repair template.
ZFN-3: Genes encoding Zinc Finger Nucleases (ZFN) are delivered to plant cells along with 
a large stretch of DNA, whose ends are homologous to the DNA sequences flanking the 
cleavage site resulting from the DNA double strand break. As a result, the DNA stretch is 
site-specifically inserted into the plant genome. 
 
European Commission 
 
EUR 25237 EN – Joint Research Centre – Institute for Prospective Technological Studies 
Title: Comparative regulatory approaches for new plant breeding techniques - Workshop Proceedings 
Authors: Maria Lusser and Emilio Rodríguez Cerezo 
Luxembourg: Publications Office of the European Union 
2012 
EUR – Scientific and Technical Research series – ISSN 1831-9424 
ISBN 978-92-79-23178-0  
doi:10.2791/73498 
 
Abstract 
 
The JRC-IPTS organized a workshop on "Comparative approaches for new plant breeding techniques" in 
September 2011. In this workshop, the regulatory framework for biotechnology derived crops with specific 
focus on approaches for new plant breeding techniques in Argentina, Australia, Canada, the European Union, 
Japan and South Africa was presented by experts from these countries. Additionally, experts discussed 
approaches and decisions for specific groups of new plant breeding techniques. 
 
Whereas, in Canada products derived through biotechnology are treated as any other novel products (plants 
with novel traits, PNTs), specific biotechnology or GMO legislation was introduced in the other five countries. 
Experience with the regulation of crops obtained by new plant breeding techniques is very limited globally. 
While initial decisions have already been taken in a few countries, discussions have only just started in others. 
Deviating decisions (between countries and between techniques) have to be expected. 
 
The workshop presentations are accessible through the following link: 
 
http://ipts.jrc.ec.europa.eu/presentations/NPBT.cfm
How to obtain EU publications 
Our priced publications are available from EU Bookshop (http://bookshop.europa.eu), where you can 
place an order with the sales agent of your choice. 
The Publications Office has a worldwide network of sales agents. You can obtain their contact details by 
sending a fax to (352) 29 29-42758. 
The mission of the Joint Research Centre is to provide customer-driven scientific 
and technical support for the conception, development, implementation and 
monitoring of European Union policies. As a service of the European Commission, 
the Joint Research Centre functions as a reference centre of science and technology 
for the Union. Close to the policy-making process, it serves the common interest of 
the Member States, while being independent of special interests, whether private or 
national. 
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